These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 32707440)

  • 1. Safety profile of the antiviral drug remdesivir: An update.
    Fan Q; Zhang B; Ma J; Zhang S
    Biomed Pharmacother; 2020 Oct; 130():110532. PubMed ID: 32707440
    [No Abstract]   [Full Text] [Related]  

  • 2. Remdesivir for the treatment of COVID-19 in pregnancy.
    Lampejo T
    J Med Virol; 2021 Jul; 93(7):4114-4119. PubMed ID: 33788273
    [No Abstract]   [Full Text] [Related]  

  • 3. Remdesivir (Veklury) for COVID-19.
    Med Lett Drugs Ther; 2020 Nov; 62(1612):186-188. PubMed ID: 33443491
    [No Abstract]   [Full Text] [Related]  

  • 4. COVID-19 updates: Remdesivir (Veklury) in high-risk outpatients with COVID-19.
    Med Lett Drugs Ther; 2022 Feb; 64(1644):31-32. PubMed ID: 35171898
    [No Abstract]   [Full Text] [Related]  

  • 5. Remdesivir for patients with COVID-19.
    Wu PE; Morris AM
    CMAJ; 2021 Jan; 193(4):E125. PubMed ID: 33408097
    [No Abstract]   [Full Text] [Related]  

  • 6. Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 1).
    Qaseem A; Yost J; Etxeandia-Ikobaltzeta I; Abraham GM; Jokela JA; Forciea MA; Miller MC; Humphrey LL; ; Centor RM; Andrews R; Haeme R; Kansagara DL; Marcucci M
    Ann Intern Med; 2021 Feb; 174(2):229-236. PubMed ID: 33017175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Not Available].
    Wu PE; Morris AM
    CMAJ; 2021 Apr; 193(14):E495-E496. PubMed ID: 33824151
    [No Abstract]   [Full Text] [Related]  

  • 8. Remdesivir as a broad-spectrum antiviral drug against COVID-19.
    Hong YN; Xu J; Sasa GBK; Zhou KX; Ding XF
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):541-548. PubMed ID: 33506946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remdesivir potently inhibits carboxylesterase-2 through covalent modifications: signifying strong drug-drug interactions.
    Shen Y; Eades W; Yan B
    Fundam Clin Pharmacol; 2021 Apr; 35(2):432-434. PubMed ID: 33369768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular Considerations of Remdesivir and Favipiravir in the Treatment of COVID-19.
    Shahrbaf MA; Tabary M; Khaheshi I
    Cardiovasc Hematol Disord Drug Targets; 2021; 21(2):88-90. PubMed ID: 34387172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 update: Remdesivir (Veklury) FDA-approved for children <12 years old.
    Med Lett Drugs Ther; 2022 Jun; 64(1652):e1. PubMed ID: 35657368
    [No Abstract]   [Full Text] [Related]  

  • 12. Missed Opportunities on Emergency Remdesivir Use.
    Sarpatwari A; Kaltenboeck A; Kesselheim AS
    JAMA; 2020 Jul; 324(4):331-332. PubMed ID: 32579163
    [No Abstract]   [Full Text] [Related]  

  • 13. Remdesivir in the COVID-19 Pandemic: An Analysis of Spontaneous Reports in VigiBase During 2020.
    Rocca E; Gauffin O; Savage R; Vidlin SH; Grundmark B
    Drug Saf; 2021 Sep; 44(9):987-998. PubMed ID: 34374967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remdesivir for the treatment of COVID 19: review of the pharmacological properties, safety and clinical effectiveness.
    Mechineni A; Kassab H; Manickam R
    Expert Opin Drug Saf; 2021 Nov; 20(11):1299-1307. PubMed ID: 34338121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update Alert 2: Remdesivir for Adults With COVID-19.
    Kaka AS; MacDonald R; Linskens EJ; Wilt TJ
    Ann Intern Med; 2021 Dec; 174(12):W114-W115. PubMed ID: 34606312
    [No Abstract]   [Full Text] [Related]  

  • 16. Bradycardia associated with remdesivir therapy for COVID-19 in a 59-year-old man.
    Day LB; Abdel-Qadir H; Fralick M
    CMAJ; 2021 Apr; 193(17):E612-E615. PubMed ID: 33903133
    [No Abstract]   [Full Text] [Related]  

  • 17. Audio Interview: New Data on Remdesivir in Covid-19.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 May; 382(22):e94. PubMed ID: 32459948
    [No Abstract]   [Full Text] [Related]  

  • 18. Hydroxychloroquine and Remdesivir in COVID-19: A critical analysis of recent events.
    Dang A; Vallish BN; Dang S
    Indian J Med Ethics; 2020; V(3):202-207. PubMed ID: 33295289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients.
    Gottlieb RL; Vaca CE; Paredes R; Mera J; Webb BJ; Perez G; Oguchi G; Ryan P; Nielsen BU; Brown M; Hidalgo A; Sachdeva Y; Mittal S; Osiyemi O; Skarbinski J; Juneja K; Hyland RH; Osinusi A; Chen S; Camus G; Abdelghany M; Davies S; Behenna-Renton N; Duff F; Marty FM; Katz MJ; Ginde AA; Brown SM; Schiffer JT; Hill JA;
    N Engl J Med; 2022 Jan; 386(4):305-315. PubMed ID: 34937145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update Alert 2: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2).
    Qaseem A; Yost J; Etxeandia-Ikobaltzeta I; Abraham GM; Jokela JA; Miller MC; Forciea MA; Humphrey LL;
    Ann Intern Med; 2021 Dec; 174(12):W116-W117. PubMed ID: 34606308
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.